Wolfe Research lowered the firm’s price target on Moderna (MRNA) to $25 from $35 and keeps an Underperform rating on the shares. The firm ...

Wolfe Research analyst Shweta Khajuria adjusted the price target for The Trade Desk (NASDAQ:TTD) shares, reducing it to $100 from the previous target of $155, while continuing to endorse the stock ...

Wolfe Research adjusted its stance on Fluence Energy Inc. (NASDAQ: NASDAQ:FLNC), downgrading the stock from Outperform to Peerperform. The downgrade comes amid a significant stock decline, with ...

Investing.com - U.S. President Donald Trump's reciprocal tariff policy is likely to face an elongated implementation timeline ...

The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 ...

CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...

Wolfe Research Auto, Auto Tech and Semiconductor Conference February 12, 2025 8:50 AM ETCompany ParticipantsMark ...

The company noted that short-term Bakken headwinds have caused Oneok's stock to lose favor, but the discount is warranted and offers a purchasing opportunity.According to Wolfe, Oneok's recent ...

Oneok (NYSE:OKE) +3.9% in Monday's trading as Wolfe Research upgrades shares to Outperform from Peer Perform with a $110 price target, saying the stock has fallen out of favor on near-term Bakken ...

Investing.com - U.S. President Donald Trump's reciprocal tariff policy is likely to face an elongated implementation timeline ...